Sibel Health, a leader in wearable biosensing and digital health, today announced that it has been awarded a competitive ...

YaoPharma will complete the ongoing Phase 1 study before handing development rights to Pfizer. ・YaoPharma will receive a $150 ...

The FDA has cleared the first artificial intelligence (AI) drug development tool to help evaluate fatty liver disease in ...

In the final part of his Pharma Commerce video interview, Ed Schoonveld, value and access advisor for Schoonveld Advisory and ...

The U.S. Food and Drug Administration has qualified the first artificial intelligence tool designed to help doctors assess a ...

A new chemical method that could speed up the creation of medicines, materials and products people rely on every day has been ...

I use the word 'trial' but, let's be honest, this is an experiment. A state-sanctioned exercise which, no matter how it is ...

CDMOs have become structural pillars of drug development, keeping pipelines moving, absorbing operational shocks, and turning ...

Pfizer Inc. has entered into an exclusive global collaboration and licensing deal with a unit of Shanghai Fosun ...

An industry-focused, end-to-end meeting covering neurodegenerative R&D from early discovery through late-stage clinical and ...

Eli Lilly’s new oral GLP-1 drug, orforglipron, is shaping up to be a major development in obesity treatment, showing nearly ...

The status could support staged transitions to new manufacturing processes, potentially mitigating some risks of high-stakes ...